Novo Nordisk (NVO)

Novo Nordisk (NVO) Stock Price & Analysis


NVO Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$94.48 - $172.97
Previous Close$157.85
Average Volume (3M)1.44M
Market Cap
Enterprise Value$347.14B
Total Cash (Recent Filing)kr23.90B
Total Debt (Recent Filing)kr25.78B
Price to Earnings (P/E)41.6
Aug 10, 2023
1.26 (0.79%)
Share Statistics
EPS (TTM)3.80
Shares Outstanding1,720,000,000
10 Day Avg. Volume1,437,976
30 Day Avg. Volume1,444,778
Standard Deviation0.06
Financial Highlights & Ratios
Price to Book (P/B)9.27
Price to Sales (P/S)1.56
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside8.24% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1



Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Novo Nordisk’s price range in the past 12 months?
Novo Nordisk lowest stock price was $94.48 and its highest was $172.97 in the past 12 months.
    What is Novo Nordisk’s market cap?
    Currently, no data Available
    When is Novo Nordisk’s upcoming earnings report date?
    Novo Nordisk’s upcoming earnings report date is Aug 10, 2023 which is in 64 days.
      How were Novo Nordisk’s earnings last quarter?
      Novo Nordisk released its earnings results on May 04, 2023. The company reported $1.296 earnings per share for the quarter, beating the consensus estimate of $1.243 by $0.053.
        Is Novo Nordisk overvalued?
        According to Wall Street analysts Novo Nordisk’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Novo Nordisk pay dividends?
          Novo Nordisk pays a Semiannually dividend of $0.85 which represents an annual dividend yield of 0.8%. See more information on Novo Nordisk dividends here
            What is Novo Nordisk’s EPS estimate?
            Novo Nordisk’s EPS estimate is $1.28.
              How many shares outstanding does Novo Nordisk have?
              Novo Nordisk has 1,717,564,000 shares outstanding.
                What happened to Novo Nordisk’s price movement after its last earnings report?
                Novo Nordisk reported an EPS of $1.296 in its last earnings report, beating expectations of $1.243. Following the earnings report the stock price went down -4.375%.
                  Which hedge fund is a major shareholder of Novo Nordisk?
                  Among the largest hedge funds holding Novo Nordisk’s share is Fisher Asset Management LLC. It holds Novo Nordisk’s shares valued at 1B.


                    Novo Nordisk Stock Smart Score

                    The Novo Nordisk stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                    Learn more about TipRanks Smart Score

                    Company Description

                    Novo Nordisk

                    Novo Nordisk A/S is a Denmark-based healthcare company, which manufactures and markets pharmaceutical products globally. The company operates through two segments, including Diabetes & Obesity Care, and Biopharmaceuticals. The company was founded in 1925.


                    Top 5 ETFs holding NVO

                    Market Value
                    Smart Score
                    VanEck Pharmaceutical ETF
                    Evolve Global Healthcare Enhanced Yield Fund Trust Units USD Unhedged
                    Evolve Global Healthcare Enhanced Yield Fund
                    Invesco International Dividend Achievers ETF
                    Brompton Global Healthcare Income & Growth ETF USD Trust Unit
                    Up to five ETFs with an Outperform Smart Score that hold NVO. The ETFs are listed according to market value of NVO within the ETF


                    Forecast EPS vs Actual EPS

                    Similar Stocks
                    Price & Change
                    Eli Lilly & Co

                    Popular Stocks

                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis